Skip to main content

Table 1 Baseline information

From: Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India

Characteristic

Study site

Overall (N = 234)

Chennai (N = 66)

Nadiad (N = 92)

Rourkela (N = 76)

Age (years)

32 (25–48)

29 (15.5–41)

23 (11–35)

29 (17–40)

Gender, male

41 (62.1)

60 (65.2)

45 (59.2)

146 (62.4)

Bed net use

64 (97)

83 (90.2)

18 (23.7)

165 (70.5)

Fever within last 2 weeks

20 (32.8)

29 (31.5)

10 (13.2)

59 (25.8)

Fever suppressant

54 (81.8)

29 (31.5)

19 (25.0)

102 (43.6)

Taken anti-malarial drugs in last 2 weeks

1 (1.6)

4 (4.3)

3 (3.9)

8 (3.4)

Malaria in last 12 months

17 (25.8)

5 (5.4)

19 (25.0)

41 (17.5)

RDT positive

25 (37.9)

45 (48.9)

8 (10.5)

78 (33.3)

Microscopy positive

28 (42.4)

48 (52.2)

13 (17.1)

89 (38.0)

PCR positive

37 (56.1)

49 (53.3)

28 (36.8)

114 (48.7)

Malaria cases

 Asymptomatic

28 (75.7)

27 (55.1)

25 (89.3)

80 (70.2)

 Symptomatic

9 (24.3)

22 (44.9)

3 (10.7)

34 (29.8)

Parasite count

 Low (≤ 5000)

25 (86.2)

35 (72.9)

10 (58.8)

70 (74.5)

 High (> 5000)

4 (13.8)

13 (27.1)

7 (41.2)

24 (25.5)

  1. Number are expressed in n (%) and median (P25 to P75)